IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.891
EU - Europa 7.490
AS - Asia 3.581
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 5
OC - Oceania 4
AF - Africa 2
Totale 19.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.866
CN - Cina 1.868
UA - Ucraina 1.850
IE - Irlanda 1.542
TR - Turchia 1.389
SE - Svezia 960
GB - Regno Unito 809
IT - Italia 723
FR - Francia 600
DE - Germania 553
FI - Finlandia 348
IN - India 281
RU - Federazione Russa 28
EU - Europa 26
CA - Canada 19
PL - Polonia 17
BE - Belgio 15
AT - Austria 13
IL - Israele 12
IR - Iran 12
NL - Olanda 6
VN - Vietnam 6
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CZ - Repubblica Ceca 4
MX - Messico 4
RS - Serbia 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
JP - Giappone 2
NZ - Nuova Zelanda 2
SG - Singapore 2
SI - Slovenia 2
TW - Taiwan 2
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KR - Corea 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 19.003
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.153
Dublin 1.532
Chandler 1.452
Princeton 744
Izmir 730
Southend 656
Nanjing 603
Wilmington 383
Cambridge 340
Ashburn 308
Dearborn 298
Beijing 297
Altamura 295
Nanchang 224
Ann Arbor 164
Chieti 124
Hebei 103
Shenyang 102
Woodbridge 101
Boardman 95
Tianjin 91
Kunming 87
New York 71
Jiaxing 69
Washington 69
Grevenbroich 67
Norwalk 56
Changsha 52
Hangzhou 35
Augusta 31
Orange 31
Jinan 28
Changchun 27
Lanzhou 26
Los Angeles 26
San Mateo 25
Ningbo 22
Houston 20
Falls Church 19
Seattle 19
Leawood 18
Brussels 15
Toronto 15
Helsinki 14
Rome 14
Zhengzhou 12
Pescara 11
Haikou 10
Hefei 10
Shanghai 10
Auburn Hills 9
Pune 9
Cedar Knolls 8
Tappahannock 8
Andover 7
Fuzhou 7
Guangzhou 7
Meylan 7
Bologna 6
Caserta 6
Dong Ket 6
Edinburgh 6
Simi Valley 6
Walnut 6
Düsseldorf 5
Milan 5
Mountain View 5
Saint-prix 5
Taizhou 5
Catania 4
Chongqing 4
Kraków 4
Lanciano 4
Palermo 4
Radomsko 4
Secaucus 4
Taiyuan 4
Torino 4
Anzola Dell'emilia 3
Ardabil 3
Bassano Del Grappa 3
Belgrade 3
Hanover 3
Kocaeli 3
L'aquila 3
London 3
Mexico City 3
Monmouth Junction 3
Montegranaro 3
Montréal 3
Paris 3
Perugia 3
Redmond 3
Rio Saliceto 3
Warsaw 3
Wuhan 3
Ancona 2
Ascoli Piceno 2
Auckland 2
Barrington 2
Totale 11.925
Salva come PNG Salva come JPEG
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 118
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 113
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 105
Pentraxin 3 and platelet activation in obese patients after gastric banding 104
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 104
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 102
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 99
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 99
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 98
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 97
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 94
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 93
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 92
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 91
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 89
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 89
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 87
Platelet activation in obesity and metabolic syndrome. 86
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 86
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 86
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 85
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 84
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 84
Platelets and Diabetes 84
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 84
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 83
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 83
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 82
Determinants of platelet activation in hypertensives with microalbuminuria. 82
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 81
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 81
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 81
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 80
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 80
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 80
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 80
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 80
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 79
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 79
Platelets and diabetes mellitus 79
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 79
Soluble forms of RAGE in internal medicine. 78
A comparison of five maintenance therapies for reflux esophagitis 77
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 77
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 77
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 77
Atherothrombotic disease and the metabolic syndrome. 76
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 76
Coagulation and infective endocarditis: sooner or later 75
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 74
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 74
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 74
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 74
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 74
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 74
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 73
Leptin increase is associated with markers of the hemostatic system in obese healthy women 73
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 73
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 73
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 73
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 73
Antipsychotic prescription and mortality in hospitalized older persons 73
Increased soluble CD40L levels in cystic fibrosis 72
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 71
Diabetes mellitus and thrombosis 71
What do we know about obesity? 71
Soluble RAGE in type 2 diabetes: association with oxidative stress. 70
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 70
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 70
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 70
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 70
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 70
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 70
Homocysteine modulates the CD40/CD40L system 69
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 69
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 69
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 69
The left atrial appendage: from embryology to prevention of thromboembolism 69
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 69
Endothelial dysfunction and oxidative stress in arterial hypertension. 68
Increased levels of soluble P-selectin in hypercholesterolemic patients 68
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 68
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 68
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 68
Nutraceuticals in diabetes and metabolic syndrome. 67
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 67
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 67
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 67
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 67
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 67
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 67
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 67
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 67
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 67
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 66
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 66
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 66
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 66
Unveiling the inflammatory face of antiplatelet drugs. 65
Totale 7.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019869 0 0 0 0 0 0 0 0 0 16 23 830
2019/20204.691 1.529 343 53 107 398 224 532 470 117 428 466 24
2020/20212.055 391 12 386 11 120 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.430 432 654 236 425 385 931 302 299 529 45 99 93
2023/20241.803 141 79 138 51 121 642 508 72 18 33 0 0
Totale 20.094